SCHRODER INVESTMENT MANAGEMENT GROUP
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1086619
London, X0
Position in HALO
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$11,149,901
+$1,920,448 QoQ
Shares Held
172,519
+25.8% QoQ
Ownership
0.145%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SCHRODER INVESTMENT MANAGEMENT GROUP holds $603,082,920 across 77 Biotechnology names. HALO ranks #16 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
163,898 | $73,187,011 | |
| 2 | TECH |
BIO-TECHNE Corp
|
1,197,214 | $62,566,403 | |
| 3 | EXEL |
Exelixis, Inc.
|
525,533 | $22,540,109 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
66,662 | $22,056,454 | |
| 5 | SLNO |
Soleno Therapeutics Inc
|
648,827 | $21,722,727 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
39,852 | $20,861,326 | |
| 7 | INSM |
INSMED Inc
|
119,958 | $19,615,531 | |
| 8 | VERA |
Vera Therapeutics, Inc.
|
484,381 | $19,486,647 |
All Filings in HALO
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,149,901 | 172,519 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $9,229,453 | 137,139 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $9,942,335 | 135,565 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $12,847,638 | 246,975 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $15,474,370 | 242,507 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,183,518 | 87,503 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $8,376,443 | 146,339 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $763,408 | 14,580 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $6,735,753 | 165,579 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,298,912 | 62,200 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $647,528 | 17,952 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $20,426,303 | 534,860 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $5,850,287 | 102,817 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,628,928 | 41,197 | Shares | Sole | 2022-11-14 | |
| 2021-09-30 | $3,320,992 | 81,637 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $29,637,199 | 652,658 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $23,209,906 | 556,726 | Shares | Sole | 2021-05-28 | |
| 2020-12-31 | $4,838,914 | 113,297 | Shares | Sole | 2021-02-24 | |
| 2020-09-30 | $3,754,071 | 142,849 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||